These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35789418)

  • 1. Efficacy of Doppler echocardiography-guided ivabradine therapy.
    Izumida T; Imamura T; Kinugawa K
    Heart Vessels; 2023 Jan; 38(1):49-55. PubMed ID: 35789418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart Failure.
    Imamura T; Kinugawa K
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Heart Rate Modulation Using Ivabradine.
    Imamura T; Kinugawa K
    Int Heart J; 2021 Jul; 62(4):717-721. PubMed ID: 34276025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
    Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of heart rate reduction with ivabradine on the international ındex of erectile function (IIEF-5) in patients with heart failure.
    Mert KU; Dural M; Mert GÖ; Iskenderov K; Özen A
    Aging Male; 2018 Jun; 21(2):93-98. PubMed ID: 28844168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
    Komajda M; Isnard R; Cohen-Solal A; Metra M; Pieske B; Ponikowski P; Voors AA; Dominjon F; Henon-Goburdhun C; Pannaux M; Böhm M;
    Eur J Heart Fail; 2017 Nov; 19(11):1495-1503. PubMed ID: 28462519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure.
    Ye F; Wang X; Wu S; Ma S; Zhang Y; Liu G; Liu K; Yang Z; Pang X; Xue L; Lu S; Zhong M; Li J; Yu H; Lou D; Cui D; Xie X; Wang J;
    J Am Coll Cardiol; 2022 Aug; 80(6):584-594. PubMed ID: 35926931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure.
    Das D; Savarese G; Dahlström U; Fu M; Howlett J; Ezekowitz JA; Lund LH
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28903983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of Doppler Echocardiography-guided Heart Rate Modulation Using Ivabradine.
    Hori M; Imamura T; Narang N; Kinugawa K
    Intern Med; 2021 Dec; 60(24):3873-3877. PubMed ID: 34148961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study.
    Bagriy AE; Schukina EV; Samoilova OV; Pricolota OA; Malovichko SI; Pricolota AV; Bagriy EA
    Adv Ther; 2015 Feb; 32(2):108-19. PubMed ID: 25700807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Implications of Mitral Valve Inflow Pattern Overlap during Ivabradine Therapy.
    Imamura T; Hori M; Narang N; Besser S; Kinugawa K
    Int Heart J; 2022; 63(1):43-48. PubMed ID: 35095075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients.
    Reil JC; Tardif JC; Ford I; Lloyd SM; O'Meara E; Komajda M; Borer JS; Tavazzi L; Swedberg K; Böhm M
    J Am Coll Cardiol; 2013 Nov; 62(21):1977-1985. PubMed ID: 23933545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivabradine in Severe Aortic Stenosis with Poor Left Ventricular Ejection Fraction.
    Huang D; Chan PH; Lam CC; Shea PC; Yiu KH; Tse HF; Siu CW
    J Heart Valve Dis; 2015 Jul; 24(4):433-5. PubMed ID: 26897811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study].
    Hu DY; Huang DJ; Yuan ZY; Zhao RP; Yan XW; Wang MH;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):190-197. PubMed ID: 28316174
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients.
    Bonadei I; Sciatti E; Vizzardi E; Fabbricatore D; Pagnoni M; Rossi L; Carubelli V; Lombardi CM; Metra M
    Cardiovasc Ther; 2018 Jun; 36(3):e12323. PubMed ID: 29460403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Ivabradine on Health-Related Quality of Life of Patients with Ischaemic Chronic Heart Failure.
    Sallam M; Al-Saadi T; Alshekaili L; Al-Zakwani I
    Curr Vasc Pharmacol; 2016; 14(5):481-486. PubMed ID: 27145825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
    Borer JS; Deedwania PC; Kim JB; Böhm M
    Am J Cardiol; 2016 Dec; 118(12):1948-1953. PubMed ID: 27780557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy.
    Böhm M; Borer JS; Camm J; Ford I; Lloyd SM; Komajda M; Tavazzi L; Talajic M; Lainscak M; Reil JC; Ukena C; Swedberg K
    Eur J Heart Fail; 2015 May; 17(5):518-26. PubMed ID: 25801408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.